Email The Therapeutic Goods Administration is not ushering home grown technology to the front of the regulatory queue, Additive Surgical says, putting millions in revenue on hold.
Want to change how you receive these emails? Manage your newsletter preferences or unsubscribe from this newsletter. Sent by The Advertiser, GPO Box 339, Adelaide SA 5001, Australia.